Aemetis (NASDAQ:AMTX) Director Timothy Alan Simon Sells 10,000 Shares

Aemetis, Inc (NASDAQ:AMTX) Director Timothy Alan Simon sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $2.05, for a total transaction of $20,500.00. Following the completion of the transaction, the director directly owned 42,632 shares in the company, valued at $87,395.60. This trade represents a 19.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Aemetis Price Performance

AMTX opened at $2.01 on Friday. The company’s 50 day simple moving average is $2.57 and its two-hundred day simple moving average is $2.02. Aemetis, Inc has a 1-year low of $1.30 and a 1-year high of $3.80. The firm has a market capitalization of $141.51 million, a price-to-earnings ratio of -1.69 and a beta of 1.36.

Aemetis (NASDAQ:AMTX) last released its earnings results on Thursday, May 7th. The specialty chemicals company reported ($0.33) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.06). The business had revenue of $54.62 million for the quarter, compared to analyst estimates of $66.70 million. On average, equities analysts anticipate that Aemetis, Inc will post -1.11 earnings per share for the current fiscal year.

Institutional Trading of Aemetis

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. acquired a new stake in Aemetis in the 3rd quarter valued at approximately $86,000. Jump Financial LLC acquired a new stake in Aemetis in the 2nd quarter valued at approximately $64,000. Graham Capital Management L.P. acquired a new stake in Aemetis in the 4th quarter valued at approximately $45,000. Centiva Capital LP acquired a new stake in Aemetis in the 3rd quarter valued at approximately $39,000. Finally, HRT Financial LP acquired a new stake in Aemetis in the 4th quarter valued at approximately $36,000. Institutional investors and hedge funds own 27.02% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on AMTX shares. Wall Street Zen downgraded shares of Aemetis from a “hold” rating to a “sell” rating in a report on Saturday, June 6th. Ascendiant Capital Markets raised their price target on shares of Aemetis from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a report on Monday, April 20th. Finally, Loop Capital set a $1.75 price target on shares of Aemetis in a report on Thursday, March 12th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $8.92.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.